BVALX | VMVAX | BVALX / VMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 7 years | 13 years | - |
Gain YTD | 1.704 | 2.745 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.96B | 30.1B | 7% |
Annual Yield % from dividends | 1.61 | 2.14 | 75% |
Returns for 1 year | 7.14 | 17.93 | 40% |
Returns for 3 years | 16.46 | 11.64 | 141% |
Returns for 5 years | 38.46 | 38.32 | 100% |
Returns for 10 years | N/A | 93.65 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JEVCX | 8.79 | 0.13 | +1.50% |
JHancock Disciplined Value Em Mkts Eq C | |||
FEYTX | 26.39 | 0.18 | +0.69% |
Fidelity Advisor Asset Manager 85% M | |||
IJSTX | 16.10 | 0.08 | +0.50% |
VY® JPMorgan Small Cap Core Equity S2 | |||
OAZEX | 17.81 | 0.06 | +0.34% |
Oakmark International Small Cap R6 | |||
CMRCX | 9.91 | 0.02 | +0.20% |
Calamos Merger Arbitrage C |